5G

Biogen and Eisai Report Data from Long-Term Extension Phase 1b Study of Investigational Alzheimerâ s Disease Treatment Aducanumab

Chief Editor August 28, 2018 0 12 sec read
Data Includes Additional Analyses of Long-Term Extension Phase 1b Study With Titration Cohort at 36 Months and Fixed-Dose Cohorts at 48 Months.

CAMBRIDGE, Mass., Aug. 28, 2018 (GLOBE NEWSWIRE) — Biogen (Nasdaq: BIIB) and Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai†) announced….

Posted: 2018-08-28 13:46:00

Read all

Chief Editor

View More Posts

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Global Connected Car Market Report 2013-2018

DUBLIN, Dec. 17, 2013 /PRNewswire/ — Research and Markets (http://www.researchandmarkets.com/research/ptdjpl/connected_car) has announced the addition of the “Global Connected Car Market Report 2013-2018” report to their […]

December 17, 2013 0 9 sec read

Back to the drawing board over Akamas

The government is set to go back to the drawing board over its Akamas plan after the Supreme Court overturned a cabinet decision over the […]

April 22, 2016 0 14 sec read

OnePlus 5 is not your typical flagship [Review]

Also, there is electronic image stabilization available for the standard camera, but nothing for the telephoto camera. Optical image stabilization is not part of the […]

September 28, 2017 0 13 sec read

Astellia : and Zain Saudi Arabia win the prestigious GTB Innovation Award for Predictive CEM Analytics

About GTB Innovation Awards 2017. GTB recognizes the industry’s most innovative & successful project partnerships between operators and vendors over the last 12 months, be […]

May 29, 2017 0 12 sec read